Noradrenaline plays an important role in the modulation of atrial electrophysiology. However, the identity of the modulated channels, their mechanisms of modulation, and their role in the action potential remain unclear. This study aimed to investigate the noradrenergic modulation of an atrial steady-state outward current (I Kss ).
Introduction
Cardiac sympathetic activity plays an important role in electrophysiological responses of the atria and in the genesis of atrial tachyarrhythmias. 1, 2 Noradrenaline is the principal neurotransmitter released from sympathetic postganglionic fibres and acts via a 1 -, b 1 -, and b 2 -adrenoceptors through multiple signalling pathways to modulate atrial ion channel and transporter function and thereby electrophysiological activity. 1 -3 For example, the action of b-adrenoceptor stimulation on Ca 2+ entry via L-type Ca 2+ channel current (I CaL ) and sarcoplasmic reticulum function underlies the positive inotropic response to sympathetic activity and, under pathological conditions in the predisposed heart, may contribute to triggered activity through after-depolarizations and abnormal automaticity. 4, 5 On the other hand, the effects of noradrenaline on K + channel currents are likely to contribute changes in membrane excitability and repolarization. 1, 2 The inwardly rectifying background K + current (I K1 ) and the steady-state outward K + current (I Kss ) have been reported to be inhibited by a 1 -and b-adrenoceptor agonists 6 -14 and may be important in the noradrenergic control of excitability, action potential (AP) profile, and refractoriness, and may thereby contribute to the arrhythmic substrate. 2, 15, 16 However, the channels contributing to the effects of noradrenergic activation on atrial I K1 and I Kss and the receptor/signalling pathways remain unresolved. Moreover, since many of the previous studies on I K1 and I Kss have been conducted using receptor-selective combinations of agonists and antagonists, the net effect of the physiological agonist, noradrenaline, is often unclear.
6 -14 I K1 is largely carried by inward rectifier K + (K ir 2.x) channels, although the two-pore domain K + (K 2P ) channel, TWIK-1 (K 2P 1.1), may also contribute. 16, 17 The inward rectifier channels, K ir 3.1 and K ir 3.4, form a heteromultimeric G-protein-gated channel that underlies the current activated by acetylcholine (I KACh ) via a pertussis toxin (PTX)-sensitive mechanism in atrial myocytes. 16 A number of K + channels have been proposed to be involved in I Kss , although the precise molecular composition of the underlying channels remains unclear. The voltage-and time-dependent kinetics of I Kss are distinct from those of the delayed rectifier currents, I Kr and I Ks. 18 The lack of detectable inactivation, together with relative insensitivity to 4-aminopyridine (4-AP), distinguishes I Kss from the ultra-rapidly activating delayed rectifier current (I Kur ). 15, 19 The two-pore domain K + (K 2P ) channel, TREK-1 (K 2P 2.1), is a weakly voltage-dependent arachidonic acid-and mechano-sensitive channel expressed in the heart that is suggested to contribute to I Kss and is modulated by isoprenaline in atrial myocytes. 17,20 -24 TASK-1 (K 2P 3.1) is an acid-sensitive K 2P channel proposed to contribute to cardiac background currents and suggested to be under G-protein-coupled receptor control. 25 -30 In addition, the six transmembrane-domain voltage-gated K + channel, SLICK (slo2.1 or
, is a Ca 2+ -independent homologue of the BK channel (slo1.1 or K Ca 1.1) that is expressed in the heart and has been suggested to contribute to a 1A -adrenoceptor-sensitive I Kss in ventricular myocytes. 14, 31 Much of the work characterizing the properties of I Kss and its modulation by adrenoceptors has been conducted in rat cardiac myocytes. 6,12,14,15,20 -22,26 -28,30 Therefore, the objectives of this study were to investigate the channels and the receptor pathways involved in the effect of noradrenaline on whole-cell I Kss in atrial myocytes from the rat heart and to examine the contribution of I Kss to changes in the atrial AP.
Methods
Further details are available in Supplementary material online. Figure S1 ). For K + -free recordings, the external and internal solutions were created by equimolar replacement of KCl with CsCl. Iso-osmotic solution consisted of (in mM) 90 NaCl, 
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PTX treatment of atrial myocytes
Atrial myocytes were incubated with PTX (1.5 mg/mL) at 378C for 3 h. Treatment with PTX under these conditions was sufficient to abolish the activation of I KACh by 1 mM ACh.
Drugs and reagents
All reagents were purchased from Sigma-Aldrich (Poole, UK), except PTX (Merck Chemicals Ltd, Nottingham, UK). Noradrenaline, fenoterol, atenolol, propranolol, ICI-118,551, zinc, fluoxetine, and mibefradil were dissolved in deionized water (dH 2 O) as 10 mM stock solutions and dissolved to the final concentration in the extracellular solution on the day of experiment. Prazosin was dissolved in near-absolute ethanol to make a 1 mM stock solution and dissolved to the final concentration in the extracellular solution on the day of experiment. Chromanol 293B, zinterol, and nifedipine were dissolved in dimethyl sulfoxide to make 10 mM stock solution of each drug and stored at 2208C. 4-AP was dissolved in dH 2 O to make 10 mM stock solution and the pH adjusted to 7.4 at 368C with HCl. To avoid oxidation, 5,8,11,14-eicosatetraynoic acid (EYTA-a non-metabolizable arachidonic acid analogue) was dissolved in chloroform under a nitrogen atmosphere, and all chloroform evaporated before storage at 2208C. Stock solutions were diluted to the final concentration in the extracellular solution on the day of experiment. 1 mM of the neurotransmitter was used as an effective concentration previously reported to inhibit I K1 and I Kss. 6,7 The concentrations of prazosin (5 mM), atenolol (10 mM), ICI-118,551, and propranolol (1 mM) used were chosen to achieve maximal effective blockade of, respectively, a 1 -, b 1 -, b 2 -, and combined b 1 -/b 2 -adrenoceptors. 7,33 -35 Zinterol (1 mM) and fenoterol (10 mM) were used in the presence of 10 mM atenolol to achieve selective b 2 -adrenoceptor activation. 34, 35 Protein kinase A (PKA) was inhibited using 10 mM H-89, a concentration that has been shown to inhibit phosphorylation of the cardiac a 1c L-type Ca 2+ channel subunit. 36 
Data analysis
Current and voltage recordings were analysed using IgorPro (vs3.16B, Wavemetrics, Inc., USA). The voltage-dependence of the L-type Ca 2+ current (I CaL ) and the noradrenaline-sensitive steady-state outward current were fitted with modified Boltzmann equations. The variance of the noradrenaline-sensitive, steady-state outward current was calculated from the integral of the spectral density function, as described previously. 14 
Statistical analysis
Data are presented as the mean + SEM. Sample sizes are provided in the figure legends (numbers of cells/numbers of animals). Statistical analyses were performed using Prism (vs5.01, GraphPad Software, Inc., USA). Current-voltage relations were analysed by two-way repeated-measures (RM) analysis of variance (ANOVA) with the Bonferroni post hoc test. All other results were analysed by one-way ANOVA with Bonferroni's multiple comparisons test. A P-value of ≤0.05 was considered significant.
Results
Whole-cell currents modulated by noradrenaline
Two distinct current components were activated by square-shaped depolarizing pulses (500 ms) to potentials of 220 mV and positive:
b-Adrenoceptor-sensitive atrial TREK-like current (i) an inward current that rapidly reached a peak and subsequently inactivated to a steady-state outward current level by the end of the pulse, representing the L-type Ca 2+ current (I CaL ) ( Figure 1Ai ) and (ii) a steady-state outward current that showed little inactivation at the end of the pulse ( Figure 1Aii ). I CaL showed voltage-dependent activation with V half ≈ 27 mV (k ≈ 6 mV) and a maximal inward current density at 0 mV under control conditions ( Figure 1Bi ). Superfusion of the cells with 1 mM noradrenaline produced a marked increase in I CaL across the voltage range, and this was associated with a 2.3-fold increase in G max and a 5 mV negative shift in V half . In addition, 1 mM noradrenaline also inhibited the steady-state outward current at positive potentials, the current at +50 mV being reduced by 42.1 + 4.3% (n ¼ 7/5) ( Figure 1Bii ). Note the time-independent nature of the noradrenalinesensitive outward current at +50 mV (lower panel, Figure 1Aii ). The noradrenaline-sensitive outward current component was weakly voltage-dependent (V half ¼ 2.71 + 3.22 mV, k ¼ 17.11 + 3.04 mV), being activated from potentials positive to 240 mV (inset, Figure 1Bii ). The inwardly rectifying current obtained at negative potentials using a modified ramp protocol was abolished in the absence of external K + (see Supplementary material online, Figure S1 ), demonstrating the involvement of K ir 2.x channels. 37 While 1 mM noradrenaline inhibited the steady-state outward currents evident at potentials positive to 240 mV (Figure 1Bii ), the currents negative to 240 mV were unaffected ( Figure 1C ). Thus, under the conditions of this study, noradrenaline inhibited a time-independent, outwardly rectifying weakly voltagedependent current, whereas I K1 was unaffected (see Supplementary material online, Figure S1E ). Noradrenaline (1 mM) had similar effects on whole-cell currents in isolated mouse atrial myocytes (see Supplementary material online, Figure S2 ). The effects of noradrenaline on the steady-state outward current were abolished in the absence of internal and external K + , demonstrating the K + -selective nature of the noradrenaline-sensitive I Kss (see Supplementary material online, Figure S3B ). Figure 1D ). Thus, noradrenaline was 150-fold more potent in the inhibition of I Kss than in the increase of I CaL .
Power spectral analysis of noradrenaline-sensitive I Kss
It was notable in the recordings of steady-state outward currents in the presence of K + that the level of noise in I Kss was reduced by noradrenaline ( Figure 1Aii ). This is demonstrated in Figure 2A , in which 5 DC-component-subtracted currents at +50 mV in the presence of noradrenaline (black traces) are superimposed on 5 DC-subtracted control currents (grey). This reduction in noise reflects the action of noradrenaline on the gating of the underlying K + -selective channels. Because the open-channel conductance is a function of the current variance, the power spectra provide a measure of the unitary conductance. 38 The power spectra could be described by a double Lorentzian ( Figure 2B) , in which the corner frequencies (mean values at +50 mV in parentheses), f c1 (4.1 + 1. Figure 2C , n ¼ 8/6).
Sensitivity of I Kss to K 1 channel modulators
The outward currents at positive potentials were reduced by the blocker of voltage-gated K + channels, 4-AP (3 mM), 39 although noradrenaline in the continued presence of 4-AP inhibited the current further so that the response to noradrenaline at +20 mV was reduced to 36% of control ( Figure 3A and B) . On the other hand, neither the KCNQ1/I Ks delayed rectifier channel blocker, chromanol 293B (10 mM), 40 nor the TASK-1/TASK-3 blocker, Zn 2+ (1 mM), 41, 42 had any significant effect on the response to noradrenaline, although the control steady-state outward current was reduced by 28.9 + 4.1% (n ¼ 5/2) in the presence of the divalent cation ( Figure 3B ). These data are consistent with the proposition that TASK-1/3 contributes to an outward current in rat atrial myocytes that is not modulated by noradrenaline. On the other hand, the background currents at both positive and negative potentials were markedly inhibited by the TREK-1 blockers, fluoxetine and mibefradil (see Supplementary material online, Figure S4 ). 43 -46 The fluoxetine-and mibefradil-sensitive difference currents reversed close to the K + equilibrium potential (E K ), demonstrating their K + -selectivity (see Supplementary material online, Figure S4B and D). Most strikingly, the effect of noradrenaline on the steady-state outward current was abolished in the presence of the TREK-1 channel blockers ( Figure 3B ). TREK-1 channel currents are reported to be activated by arachidonic acid and by stretch. 20 -22,24,47 The effect of the nonmetabolizable analogue of arachidonic acid, EYTA (10 mM), on the noradrenaline-sensitive current was investigated ( Figure 3C ). Superfusion of the cells with EYTA increased the steady-state outward current at +20 mV by 38.6 + 16.2% (P , 0.05; n ¼ 5/3; Figure 3C ). Addition of noradrenaline in the continued presence of EYTA resulted in a reduction of the steady-state outward current by 60.9 + 3.9% (P , 0.001; n ¼ 5/3; Figure 3C ), representing an augmentation of the response to noradrenaline of 50% ( Figure 3B) . Similarly, hyposmotic stretch also increased I Kss at +20 mV (69.7 + 17.0%, n ¼ 7/2, P , 0.05), and noradrenaline inhibited the hyposmotically potentiated current (67.0 + 12.6%; P , 0.001), representing 63% augmentation of the response to noradrenaline ( Figure 3B and D) .
Adrenoceptor subtypes in the noradrenaline response
The inhibitory effect of noradrenaline on I Kss at concentrations of 1-100 nM was strongly reduced by either the b 1 -adrenoceptor blocker, atenolol (10 mM), or b 2 -selective ICI-118,551 (100 nM; Figure 4A ). However, neither antagonist was effective against the response to 1 mM noradrenaline when applied alone ( Figure 4A ). On the other hand, the effect of 1 mM noradrenaline was markedly inhibited when the b 1 -and b 2 -antagonists, atenolol (10 mM) and ICI-118,551 (100 nM), were applied in combination ( Figure 4A ). The apparent rightward-shift in the concentration-dependence of I Kss inhibition by noradrenaline produced by either atenolol or ICI-118,551 when applied alone, taken together with the cumulative effect against 1 mM noradrenaline when the antagonists were applied in combination, demonstrates the involvement of both b 1 -and b 2 -adrenoceptor subtypes in response to noradrenaline. Consistent with this, the effect of 1 mM noradrenaline on I Kss was abolished by the non-selective b 1 -/b 2 -adrenoceptor antagonist, propranolol (1 mM; Figure 4A and B). The effect of 1 mM noradrenaline on the steady-state outward current at +20 mV (46.8 + 2.56%, n ¼ 13) was unaffected by the a-adrenoceptor antagonist, prazosin (5 mM), either applied alone (46.6 + 4.06%, n ¼ 5) or in combination with 10 mM atenolol (42.3 + 5.11%, n ¼ 5). I Kss was inhibited by b 2 -adrenoceptor-selective agonism with either zinterol (1 mM) or fenoterol (10 mM) in the presence of 10 mM atenolol, in a manner similar to noradrenaline, consistent with a role for b 2 -adrenoceptors in the inhibition of I Kss ( Figure 4D and E). The augmentation of I CaL by 1 mM noradrenaline was also completely inhibited in the presence of propranolol ( Figure 4C ). The increase of I CaL by 1 mM noradrenaline (201 + 54.6% at +10 mV, n ¼ 6, Figure 1Bi ) was also completely abolished in the presence of the b 1 -adrenoceptor antagonist, 10 mM atenolol (23.1 + 2.69%, n ¼ 5). On the other hand, zinterol had no effect on I CaL ( Figure 4F) , indicating that the effect of noradrenaline on I CaL was mediated predominantly by b 1 -adrenoceptors.
Cell signalling pathways
The b 2 -adrenoceptor couples with both G s -and G i -mediated signalling pathways. 3 G s -protein activates the adenylyl cyclase/PKA cascade involving cyclic AMP. 3 The inhibitory effect of noradrenaline on the steady-state outward current could still be observed following Figure S5 ), indicating that PKA was not essential to the action of noradrenaline on I Kss . The role of G i -proteins in the inhibitory effect of noradrenaline on the steady-state outward current was investigated by pretreatment of the cells in PTX ( Figure 5) . While the effect of noradrenaline on I CaL remained intact in PTX-treated cells ( Figure 5A) , the steady-state outward current inhibition was completely abolished ( Figure 5B and C) . Taken together, these results show that the inhibitory effect of noradrenaline on the steady-state outward current was mediated via a PTX-sensitive mechanism that did not require PKA. On the other hand, b 2 -adrenoceptors did not contribute to the potentiation of I CaL by noradrenaline, which likely involved b 1 -adrenoceptors acting via PKA.
AP prolongation by noradrenaline
The effects of noradrenaline (1 mM) on the AP were investigated ( Figure 6 ). Noradrenaline caused a delay in the early and mid-phases of repolarization, consistent with changes in I CaL and I Kss ( Figure 6A ). The effect of noradrenaline in the presence of the b 1 -antagonist, atenolol, and the non-selective b 1 -/b 2 -blocker, propranolol, is shown in Figure 6B and C, respectively. The effects of noradrenaline on mean AP duration at 30% repolarization (APD 30 ) in the absence of and the presence of the b-blockers are shown in Figure 6D . Noradrenaline caused 65% prolongation of APD 30 . Although b 1 -antagonism produced a partial reduction in APD 30 prolongation, the effect of noradrenaline was completely abolished with combined b 1 -/b 2 -blockade using either 100 nM ICI-118,551 in combination with 10 mM atenolol or 1 mM propranolol ( Figure 6D ).
Discussion
This study demonstrates for the first time the potent inhibition of a steady-state outward K + current in atrial myocytes by nanomolar concentrations of noradrenaline (IC 50 ¼ 0.90 nM). In contrast, noradrenaline was 150-fold less potent in potentiating I CaL (EC 50 ¼ 136 nM). Both b 1 -and b 2 -adrenoceptors were co-operatively involved in the inhibition of I Kss , which was via a PTX-sensitive pathway that did not require PKA. On the other hand, the potentiation of I CaL by noradrenaline was mediated via b 1 -adrenoceptors through PKA. The noradrenaline-sensitive current had pharmacological and biophysical properties consistent with the involvement of a TREK-like channel. Inhibition of I Kss contributed to the noradrenaline-induced prolongation of the AP in atrial myocytes.
Properties of noradrenaline-sensitive I Kss
The effectively instantaneous activation of the noradrenaline-sensitive steady-state outward current on depolarization positive to 240 mV and the lack of time-dependent inactivation over the course of the pulse are representative of adrenoceptor-modulated I Kss in rat ventricular myocytes reported previously and rule out contribution of the transient outward current, I to. 6,12,14 Moreover, the observation that 36% of the noradrenaline-sensitive current remained in the presence of 3 mM 4-AP indicates that I Kss was distinct from the comparatively 4-AP-sensitive I Kur /K v 1.5 channel currents that would be almost completely inhibited by the concentration of this voltage-gated K + channel blocker. 15, 19 Although control I Kss was inhibited by Zn 2+ , consistent with the contribution of TASK-1 channels to the whole-cell currents, the response to noradrenaline was unaffected, demonstrating that this K 2P channel did not contribute to the noradrenaline-sensitive current. On the other hand, the weak voltage-dependence, the potentiation by the arachidonic acid analogue, EYTA, and by osmotic stretch and the inhibition by fluoxetine, mibefradil, and Ba 2+ are all properties that noradrenaline-sensitive I Kss shares with TREK-1 channels. 20 -22,43 -47 The effects of noradrenaline on the power spectrum demonstrate unequivocally the involvement of an ion channel with flickery kinetics in I Kss . The calculated unitary conductance (8.4 pS) is close to the 14 pS originally proposed for TREK-1. 48 However, unitary current recordings of TREK-1-like channel currents in rat cardiomyocytes have suggested a conductance of 41 pS. 21, 22 The basis for the differences in reported conductance are unclear, but a number of conductance modes for the TREK-1 channel have been reported, and it has been suggested that the conductance mode depends on interaction with cytosolic regulatory proteins. 49 It is conceivable, therefore, that the noradrenaline-sensitive channel represents a lower conductance mode of TREK-1 than was evident previously in cell-attached and excised-patch recordings. 21, 22 It is notable that I Kss was also reduced by the removal of external K + in a manner reminiscent of K ir channels. Nevertheless, I Kss was distinct from I K1 , because noradrenaline had no effect on the inward rectifier currents. Interestingly, a tendency to pore collapse and non-conductive states of the channel in external K + -free conditions similar to K ir 2.1 has recently been suggested for TREK-1. 50 Thus, our data are consistent with the involvement of a TREK-1-like channel in the noradrenaline-sensitive I Kss of rat atrial myocytes. . 51 -53 Interestingly, it has been reported that b 1 -/b 2 -adrenoceptor subunits can form heterodimeric receptors in cardiomyocytes that have an increased agonist sensitivity relative to the respective homodimeric receptors. 54 Moreover, the action of noradrenaline in inhibiting I Kss with greater potency than potentiation of I CaL is consistent with a previous report of the effects of the b-agonist, isoprenaline, on I Kss and I CaL in rat ventricular myocytes. 12 The abolition of I Kss responses following pretreatment with PTX demonstrated the involvement of a G i -protein, consistent with reports of coupling of b 1 -, as well as b 2 -adrenoceptors, to G i -protein pathways in cardiomyocytes. 55, 56 The involvement of b-adrenoceptors in the inhibition of TREK-1 channel-like currents in rat atrial myocytes has been suggested previously. 21 However, the inhibitory response to noradrenaline was not abolished by treatment with H-89, indicating that PKA was not required for the regulation of I Kss . Although the effect of noradrenaline on I Kss was reduced in the presence of H-89, this was likely due to non-specific actions of the PKA inhibitor. 57 The 
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Noradrenergic inhibition of I Kss contributes to AP prolongation
Noradrenaline caused prolongation of the AP at relatively depolarized potentials, but had little effect closer to the resting membrane potential. The prolongation of APD 30 by noradrenaline was consistent with the actions of noradrenaline on I CaL and I Kss . Under the conditions of this study, it was possible to discriminate between the actions of noradrenaline on I CaL and I Kss through differences in their sensitivity to b-adrenoceptor-selective antagonists. For example, in the presence of atenolol alone, noradrenergic potentiation of I CaL would be blocked while the inhibition of I Kss would remain intact. On the other hand, in the presence of combined b 1 -/b 2 -antagonism, the effect of noradrenaline on I Kss would also be reduced. Thus, the correlation between the degree of noradrenaline-induced APD 30 prolongation and the degree of noradrenergic inhibition of I Kss in the presence of b 1 -/b 2 -non-selective propranolol, b 1 -selective atenolol, and b 2 -selective ICI-118,551 in combination and atenolol alone (see Supplementary material online, Figure S6 ) illustrated the contribution of I Kss to the noradrenergic prolongation of the AP. AP prolongation through I Kss inhibition is likely to affect sarcolemmal Ca 2+ fluxes via L-type Ca 2+ channels and the Na + /Ca 2+ exchanger and thereby to contribute to the effects of noradrenaline on atrial contractility and arrhythmogenesis.
Possible physiological significance of noradrenaline-sensitive I Kss
It has not been possible, to date, to measure directly the concentration of noradrenaline achieved at the neuroeffector junction of cardiac postganglionic fibres during sympathetic activity, but it is generally estimated to be .100 nM. 60 The EC 50 for noradrenergic potentiation of I CaL corresponds well with this value, consistent with the potentiation via b 1 -adrenoceptors of atrial Ca 2+ entry during sympathetic activity.
2,4
The 'basal' concentration of noradrenaline at the cardiac neuroeffector junction is also unknown, but it is likely to be similar to circulating concentrations of noradrenaline, which are reportedly very low (1-2 nM). 60 Since the IC 50 for inhibition of I Kss by noradrenaline was 0.90 nM, it seems likely that this current would be inhibited, contributing to AP prolongation at relatively modest levels of sympathetic activity. On the other hand, this TREK-like channel current is activated by stretch and may make a greater contribution to AP repolarization under physiological mechanical loads in vivo. 22 The inhibition by noradrenaline may provide a mechanism by which AP configuration is optimized to mechanical load and degree of autonomic activation.
Limitations
This study provides good evidence of a role for a TREK-like I Kss in repolarization of rat atrial myocytes and demonstrates the existence of a similar noradrenaline-sensitive current in mouse atrial cells. Expression of TREK-1 has recently been demonstrated in the human heart. 61 However, it is currently unclear to what extent I Kss contributes to the repolarization of the human atrium. Moreover, it is not clear whether these TREK-like currents are atrial selective. Further work is therefore merited to establish the contribution of I Kss and K 2P channels to human cardiac electrophysiology.
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